Sub-Q Bionics
Tel Aviv, Israel· Est.
Implantable bionic pump for cancer‑related lymphedema, offering continuous, drug‑free fluid management.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Estimated funding: $1.5M
AI Company Overview
Implantable bionic pump for cancer‑related lymphedema, offering continuous, drug‑free fluid management.
OncologyWomen's Health
Technology Platform
Implantable bionic pump with closed‑loop pressure sensing to continuously mobilize lymphatic fluid, paired with wireless telemetry for remote monitoring.
Opportunities
A growing global lymphedema market and lack of implantable solutions create a clear path for adoption and reimbursement, especially among oncology survivors.
Risk Factors
Regulatory approval, clinical validation, and payer reimbursement remain uncertain; competition from external compression technologies and emerging surgical approaches could limit market share.
Competitive Landscape
Few companies offer implantable lymphatic devices; Sub‑Q differentiates through a smart, wireless‑enabled pump, but must prove safety and efficacy against established compression therapies.